Cosmetic Dermal Fillers
Comprehensive and specialized principles of injecting various fillers in aesthetic medicine
- 1. Basics of clinical anatomy and the 5-layered facial structure
- 2. Understanding biomaterials and rheological properties of fillers
- 3. Specialized classification of fillers and mechanism of action
- 4. Injection principles based on anatomical areas of the face
- 5. Comparison of instruments and maneuvers: Needle vs. microcannula
- 6. Dangerous arteries, critical angles and high-risk areas
- 7. Protocols for managing complications and vascular ischemia
- 8. Vital pre- and post-operative clinical measures
1. Basics of clinical anatomy and the 5-layered facial structure
The basic principles for achieving a natural result without displacement or lumpiness of the material are to respect the tissue layering of the head and face. Each point of the face is microscopically and macroscopically composed of five distinct layers that determine the depth of the filler implantation:
Layer 1: Skin
Includes the epidermis and dermis; in cases of correction of very superficial lines (such as photoaging around the mouth) it is targeted with very low viscosity fillers.
Layer 2: Superficial Fat
Separate compartments that sag with age; excessive injection into this layer will cause facial heaviness and ptosis.
Layer 3: Musculoaponeurotic System (SMAS/Platysma)
A continuous, fibrous, muscular layer that transmits facial expression. Direct injections into this layer itself are usually avoided.
Layer 4: Loose connective tissue and gliding space (Deep Fat & Retaining Ligaments)
Deep fat attached to the skeleton along with facial ligaments that act as scaffolding to support the facial structure.
Layer 5: Periosteum
The upper surface of the bone; a key platform for true lift, angulation, and bone remodeling simulation using high-resilience fillers.
Changes due to aging are not limited to skin laxity; there is progressive resorption of the maxillary and orbital bones, shrinkage of deep fat compartments, and elongation of supporting ligaments (such as the zygomatic and mandibular ligaments). Volume restoration must be accomplished by compensating for these deficits from depth to surface.
2. Understanding biomaterials and rheological properties of fillers
A skilled physician selects the brand and type of filler based on fluid physics and mechanics factors. Ignoring rheological properties is the main cause of results such as asymmetric protrusions, material displacement during laughter, or balling:
- Modulus of elasticity (G-Prime or G'): Indicates the stiffness of the gel and its ability to resist pressure from gravity and muscle contractions. The higher the G' value, the stronger the lifting power of the filler and should be implanted in the deeper layers of the bone.
- Viscosity modulus (G-Double-Prime or G''): Indicates the gel's resistance to deformation under shear forces and manages the gel's fluid properties during injection and adaptation to skin surface movements.
- Cohesivity: The intermolecular force of adhesion of hyaluronic acid particles to each other. Fillers with high cohesiveness maintain their cohesion after injection and do not easily spread or shift in the tissue.
- Cross-linking Degree: The percentage of cross-linking agent (usually BDDE) used that determines the biostability of the gel against enzymatic degradation by the body's natural hyaluronidase.
3. Specialized classification of fillers and mechanism of action
| Name and base material | Average lifespan | Tissue mechanism | Preferred uses | Antidote and reversibility |
|---|---|---|---|---|
| Hyaluronic acid (HA) | 6 to 18 months | Direct hydration and water retention, ECM integrity | Lips, under eyes, laugh lines, cheek and temple shaping | Has (hyaluronidase enzyme) |
| Calcium Hydroxyapatite (CaHA) | 12 to 24 months | Instant volume creation with long-term tissue neocollagenesis | Jaw contour, hand volumization, biostimulator lift | No (requires time or dilution) |
| Poly-L-lactic acid (PLLA) | Up to more than 2 years | Direct stimulation of macrophages to produce collagen types 1 and 3 | Extensive facial thinning, temple hollowing, tissue sagging | No (unsolvable immediately) |
| Polycaprolactone (PCL) | 1 to 4 years | Polymer microspheres with controlled absorption and collagen formation | Permanent lifting, structural reconstruction of the dermis and subdermis | No |
While hyaluronic acid fillers are considered the gold standard of cosmetic treatments due to the presence of a specific antidote, biostimulators such as CaHA and PLLA are excellent options in advanced clinics to enhance skin quality, eliminate sagging, and add volume without excessive puffiness.
4. Injection principles based on anatomical areas of the face
Temples, eyebrows and forehead
The temple is a densely layered area with numerous vessels (especially the superficial temporal artery and its middle branch). Safe injection into the temporal fossa requires adherence to precise techniques; either a direct deep injection into the periosteum at a safe point 1 cm above the brow line and 1 cm outwards, or a superficial injection into the subcutaneous layer using a long 22- or 25-gauge cannula. In the forehead, the injection should be made completely tangentially to the bone and with very little pressure or in the subcutaneous layer without touching the trunk of the supratrochlear artery.
Tear Trough and Malar Complex (Cheek)
Injections under the eyes are among the most delicate procedures. The skin in this area is the thinnest tissue on the entire face and is prone to the Tyndall Effect (bruising and blue reflection due to light scattering from the surface gel) and persistent lymphedema. The use of a low-swelling (low hydrophilic) filler in the suborbicularis muscle, just above the bony rim of the eye socket, with a 25 or 27 gauge cannula is a must. In the cheek area, targeting the deep fat (SOOF) provides structural support and partial opening of the laugh line without unnaturally manipulating the center of the face.
Laugh lines, lips, marionette lines, and jaw angle
Lip injections should be performed in harmony with the natural geometry of the face, avoiding a duck face. Respect for the philtrum pillars, the vermilion border, and the balance of the upper and lower lips (the golden ratio of 1 to 1.6 in classic faces) is essential. In the nasolabial fold, the angle of exit of the facial artery and its location deep in the corner of the nose (angular artery) require that the injection be performed either very superficially in the dermis or with a cannula from a lateral angle. In the angle of the jaw, seating the tip of the instrument on the angle of the gonion bone creates a sharp jaw line and secondary lift of the double chin.
5. Comparison of instruments and maneuvers: Needle vs. microcannula
The choice of tissue entry tool is not random and is selected depending on the treatment goal, risk control, and thickness of the site:
- Sharp Needle: Allows micrometric control of gel exit site, ability to create precise boluses that adhere to bone, and correction of fine lines. However, it has a higher potential for vascular wall perforation and tissue ecchymosis. A needle aspiration test is required prior to injection into bone for at least 5 to 10 seconds.
- Blunt Microcannula: Instead of cutting the vessels and tissues, it pushes them aside; as a result, the risk of inadvertent entry into the vessel lumen is significantly reduced and post-treatment bruising is minimized. Cannulas with a length of 50 or 70 mm and an appropriate gauge (especially 22-25 gauge) allow access to long distances from a small entry port. Very thin cannulas (such as 30 gauge) may act like needles in dense tissue and tear vessels, so they are not recommended in high-risk areas.
6. Dangerous arteries, critical angles and high-risk areas
Warning triangles and vascular anastomosis map
The face has extensive communication pathways between the external and internal carotid systems. Intravenous injection and retrograde embolism of filler can push the material through the facial arteries to the ophthalmic and central retinal arteries, leading to irreversible blindness or even stroke in less than a few seconds.
- Glabellar and supratrochlear arteries: frown line and the area between the eyebrows; filler in this area should be administered with minimal volume, with maximum caution, and preferably replaced with buccal toxin.
- Dorsal and alar arteries of the nose: The tip and septum of the nose; have an extremely rich blood network and terminal vessels with vulnerable walls. Non-surgical rhinoplasty injections are highly susceptible to tissue necrosis of the alar and tip of the nose.
- The facial artery and superior/inferior labial branch: run deep within the lip muscles and usually 4 to 6 mm from the posterior moist mucosa. Lip injections must be deep in the anterior submucosa.
7. Protocols for managing complications and vascular ischemia
Being prepared to deal with unwanted complications is what separates an experienced injector from a layperson. Immediate intervention within the first few hours of the event determines the fate of the tissue and prevents tissue necrosis:
- Warning signs of vascular occlusion: sudden tissue pallor (blanching), severe, disproportionate, and sharp pain during injection, delayed capillary refill time (Capillary Refill Time >2 seconds), and subsequent bluish mesh appearance (Livedo Reticularis).
- High-Dose Pulsed Hyaluronidase Protocol: Stop the injection process immediately. Waiting for blisters or pus to appear is a big mistake. Inject at least 500 to 1500 units of hyaluronidase throughout the ischemic area and the relevant vascular distribution, repeating the dose if capillary refill does not return after 60 minutes.
- Complementary clinical measures: warm compresses to induce local vasodilation, application of 2% nitroglycerin paste or patch under direct supervision, gentle massage, and administration of controlled-dose oral steroids and aspirin to prevent intraluminal platelet thrombosis.
- Delayed complications and biofilms: Late inflammatory nodules, granulomatous foreign body reactions, and formation of resistant bacterial colonies. Treatment of these conditions requires a combination of dual antibiotics (such as ciprofloxacin and clarithromycin), hyaluronidase injections in the case of HA material, and avoidance of corticosteroid injections until the latent infection is completely controlled.
8. Vital pre- and post-operative clinical measures
Achieving a uniform result, ideal symmetry, and improved safety requires careful preparation and monitoring protocols:
- Before injection: Obtain a complete clinical history, screen for active autoimmune diseases, discontinue blood thinners and supplements containing vitamin E, ginkgo, and omega-3 for at least 7 days prior (in consultation with the relevant physician), review history of herpes, and prescribe prophylaxis with acyclovir for injections around the mouth.
- Immediate care and the first few days: Avoid applying pressure, sleeping on your face, going to high-temperature environments (sauna, jacuzzi, and direct sunlight), and prohibiting high-pressure sports activities for up to 48 hours to prevent exacerbation of edema and local inflammatory reactions.
- Supplementary evaluation: A follow-up examination is scheduled 14 to 21 days later to assess the final gel settlement, correct minor asymmetries resulting from swelling, and take standard medical photographs to monitor the long-term condition of the tissue.
We are with you and answer to you.
Contact our experts for expert advice or to book an appointment quickly.
Do you need guidance or an appointment ?
Our experts are ready to serve you instantly and directly.
Contact us directly
To connect with the desired section, click on the relevant option.